NEW YORK , Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). ...

核心诉讼指控 - 公司面临集体诉讼 指控其与第三方计费公司HaloMD合谋提交不符合资格的保险索赔 通过仲裁程序获取超额报销 人为提升财务表现[1][2] - 诉讼称公司收入模式建立在不可持续的基础上 数千份可疑索赔被虚假认证 仲裁驱动型收入缺乏长期可行性[2] - 公司被指控在2024年8月8日至2025年8月14日期间误导投资者 导致重大损失[2][9] 做空报告影响 - 做空机构Blue Orca Capital于2025年7月22日发布报告 指控HaloMD实施"欺诈计划"从保险公司转移数百万美元资金[3] - 报告引用Anthem和Blue Cross Blue Shield附属公司提起的诉讼 称HaloMD用无效索赔淹没仲裁系统[3] - Blue Orca警告公司对仲裁报销的依赖存在重大风险 股价可能跌至仙股水平 报告发布后股价下跌超过10%[4] 财务报告问题 - 公司被指控错误分类股票薪酬义务 将其视为股权而非负债 扭曲真实财务状[5] - 审计委员会发现医院开发相关义务存在错误分类 需对先前财务报表进行重述[7] - 公司于8月14日延迟提交10-Q表格 提及"非现金会计调整" 次日股价暴跌16.39%至92.91美元[6] 公司回应与市场反应 - 公司于7月24日否认Blue Orca指控 承诺在季度文件中澄清 但未直接回应核心指控[6][8] - 公司强调未在针对HaloMD的诉讼中被点名 但批评者认为这回避了实质问题[8] - 法律调查重点关注公司商业模式是否基于可疑仲裁策略以及财务报告是否误导投资者[10]

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=166637&wire=4 Accessibility StatementSkip Navigation NEW YORK, Sept. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("N ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Faruqi & Fa ...

集体诉讼案件核心 - 律师事务所Levi & Korsinsky代表在2024年8月8日至2025年8月14日期间因Nutex Health Inc证券欺诈而遭受损失的投资者提起集体诉讼 [1] 涉嫌欺诈行为指控 - 第三方IDR供应商HaloMD通过协同欺诈保险公司方案为Nutex获取高额仲裁收益 [2] - 源自欺诈行为的IDR流程相关收入不可持续 [2] - 公司夸大其财务报告内部控制重大弱点的整改程度及能力 [2] - 公司未能有效核算股票薪酬义务的会计处理 [2] - 错误将股票薪酬义务计为权益而非负债 [2] - 上述问题增加公司无法按时向SEC提交财务报告的风险 [2] - 公司业务及财务前景被夸大 [2] - 被告公开声明存在重大虚假和误导性 [2] 法律程序安排 - 受损投资者可在2025年10月21日前申请作为首席原告 [3] - 参与赔偿无需支付任何自付费用 [3] 律师事务所背景 - Levi & Korsinsky过去20年为受损股东追回数亿美元资金 [4] - 拥有70多名员工的专业团队 [4] - 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼事务所前50名 [4]

Accessibility StatementSkip Navigation NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX). Shareholders who purchased shares of NUTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/nutex-health-inc-loss-submission-form/?id=16 ...

Nutex Health Inc. (NASDAQ:NUTX) is set to release its quarterly earnings with an anticipated EPS of -$5.43 and projected revenue of $210.89 million.The company faces a class-action lawsuit for alleged securities law violations, with investors urged to file as lead plaintiffs by October 21, 2025.Despite legal challenges, NUTX's financial metrics such as a P/E ratio of 6.84, a price-to-sales ratio of 0.74, and an earnings yield of 14.63% provide a mixed financial outlook.Nutex Health Inc. (NASDAQ: NUTX) opera ...

集体诉讼案件核心指控 - 公司被指控在2024年8月8日至2025年8月14日期间发布重大虚假或误导性陈述[3] - 第三方供应商HaloMD涉嫌通过欺诈保险公司的协调计划为Nutex Health获取有利仲裁结果[3] - 公司被指控夸大其财务报告内部控制中重大弱点的整改程度和能力[3] 财务与运营问题 - 源于欺诈行为的IDR流程相关收入被认定为不可持续[3] - 公司未能有效核算某些股票薪酬义务的会计处理[3] - 错误地将股票薪酬义务计算为权益而非负债[3] - 上述问题增加了公司无法及时向SEC提交财务报告的风险[3] 公司前景与陈述 - 公司的业务和财务前景被指控为夸大其词[3] - 被告的公开陈述在所有相关时间均被指控存在重大虚假和误导性[3] 法律程序信息 - 集体诉讼期确定为2024年8月8日至2025年8月14日[3] - 股东登记截止日期为2025年10月21日[4] - 鼓励在上述期间购买NUTX股票的股东联系律师事务所[1]

SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Nutex Health Inc. (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025. Nutex is a physician-led, healthcare services and operations company that began publicly trading via a reverse merger in April 2022. Accessibility StatementSkip Navigation For more information, submit a form, email attorney Aaron Dumas, Jr., or g ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/nutex- ...